Please use this identifier to cite or link to this item:
|Title:||Differences in cancer survival by sex: a population-based study using cancer registry data.|
|Authors:||Afshar, Nina;English, Dallas R;Thursfield, Vicky;Mitchell, Paul L R;Te Marvelde, Luc;Farrugia, Helen;Giles, Graham G;Milne, Roger L|
|Affiliation:||Cancer Strategy and Development, Department of Health and Human Services, Melbourne, VIC, Australia|
Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia
Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia
Department of Medical Oncology, Olivia Newton John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia
Victorian Cancer Registry, Cancer Council Victoria, Melbourne, VIC, Australia
|Citation:||Cancer causes & control : CCC 2018; 29(11): 1059-1069|
|Abstract:||Few large-scale studies have investigated sex differences in cancer survival and little is known about their temporal and age-related patterns. We used cancer registry data for first primary cancers diagnosed between 1982 and 2015 in Victoria, Australia. Cases were followed until the end of 2015 through linkage to death registries. Differences in survival were assessed for 25 cancers using the Pohar-Perme estimator of net survival and the excess mortality rate ratio (EMRR) adjusting for age and year of diagnosis. Five-year net survival for all cancers combined was lower for men (47.1%; 95% CI 46.9-47.4) than women (52.0%; 95% CI 51.7-52.3); EMRR 1.13 (95% CI 1.12-1.14; p < 0.001). A survival disadvantage for men was observed for 11 cancers: head and neck, esophagus, colorectum, pancreas, lung, bone, melanoma, mesothelioma, kidney, thyroid, and non-Hodgkin lymphoma. In contrast, women had lower survival from cancers of the bladder, renal pelvis, and ureter. For the majority of cancers with survival differences, the EMRR decreased with increasing age at diagnosis; for colorectal, esophageal, and kidney cancer, the EMRR increased with time since diagnosis. Identifying the underlying reasons behind sex differences in cancer survival is necessary to address inequalities, which may improve outcomes for men and women.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.